Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Interventional Approaches to Pain and Spasticity Related to Cerebral Palsy
1
x
$
30.00
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
1
x
$
30.00
Treatment Resistant Depression with Loss of Antidepressant Response: Rapid—Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule
1
x
$
30.00
VOL 2 No. 12 Full Issue - December 2000
1
x
$
20.00
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
1
x
$
30.00
The Role of Irradiation in Endometrial Cancer
1
x
$
0.00
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
1
x
$
30.00
Use of Clozapine in the General Hospital (OPEN ACCESS)
1
x
$
0.00
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
1
x
$
30.00
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Trichotieromania and Alopecia Areata Triggered by Aripiprazole- Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity
1
x
$
30.00
Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program
1
x
$
30.00
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
1
x
$
30.00
Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists
1
x
$
30.00
Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas
1
x
$
0.00
View Cart
Checkout
Home
Store
“Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Letter From the Editors: Are We Prepared for the Genomics Era?
$
0.00
Add to cart
Details
Letter From the Editors: Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
$
0.00
Add to cart
Details
Letter From the Editors: Lymphomas – The Diseases That Taught Us Monoclonal Antibodies Can Work
$
0.00
Add to cart
Details
Letter From the Editors: Right Tool, Right Time, Right Reason
$
0.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
$
30.00
Add to cart
Details
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
$
30.00
Add to cart
Details
Lineamientos universales: Indíce de medicamentos para Latinoamérica
$
0.00
Add to cart
Details
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
$
0.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
$
30.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia
$
30.00
Add to cart
Details
Previous
1
…
21
22
23
…
44
Next
Page load link
Go to Top
